The estimated Net Worth of Greg Zante is at least 20.6 百万$ dollars as of 29 July 2024. Greg Zante owns over 16,136 units of Viking Therapeutics Inc stock worth over 11,378,373$ and over the last 21 years he sold VKTX stock worth over 9,185,802$. In addition, he makes 0$ as Senior Vice President - Finance、 IR Contact Officer at Viking Therapeutics Inc.
Greg has made over 14 trades of the Viking Therapeutics Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 16,136 units of VKTX stock worth 922,172$ on 29 July 2024.
The largest trade he's ever made was selling 161,940 units of Viking Therapeutics Inc stock on 30 March 2023 worth over 2,783,749$. On average, Greg trades about 17,158 units every 279 days since 2003. As of 29 July 2024 he still owns at least 187,052 units of Viking Therapeutics Inc stock.
You can see the complete history of Greg Zante stock trades at the bottom of the page.
Greg Zante is the Senior Vice President - Finance, IR Contact Officer at Viking Therapeutics Inc.
Greg's mailing address filed with the SEC is C/O VIKING THERAPEUTICS, INC., 9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA, 92121.
Over the last 10 years, insiders at Viking Therapeutics Inc have traded over 46,107,976$ worth of Viking Therapeutics Inc stock and bought 199,715 units worth 855,627$ . The most active insiders traders include Brian Lian、Charles A Jr Rowland、Marianna Mancini. On average, Viking Therapeutics Inc executives and independent directors trade stock every 75 days with the average trade being worth of 4,137,170$. The most recent stock trade was executed by Brian Lian on 21 August 2024, trading 1,000 units of VKTX stock currently worth 7,770$.
Viking Therapeutics Inc executives and other stock owners filed with the SEC include: